About us

The Centre for Imaging Sciences (formerly known as the Division of Imaging Science and Biomedical Engineering - ISBE) is a world-class research department focusing on imaging physics, image processing, computer vision and the development and application of imaging biomarkers in healthcare.

The Centre offers state-of-the-art medical imaging and computing facilities on the main university campus, and access to a network of more extensive research imaging facilities managed in collaboration with the University of Manchester Biomedical Imaging Institute and the NHS.

It has close links with the university teaching hospitals and with the School of Computer Science, and has received 5 and 5* (the highest possible) ratings in RAE (Research Assessment Exercise) 2001.

The multidisciplinary nature of the research means that many projects involve collaboration with colleagues in other disciplines in the Faculty of Medical and Human Sciences, and the Faculty of Life Sciences.


The Centre's research activities combine expertise in the domains of physics, mathematics, computing, bioscience and clinical medicine to develop new ideas and applications.


The Centre for Imaging Sciences is active in undergraduate, postgraduate, and professional education and training.

The Centre is active in the delivery of undergraduate courses within the medical school and within the Faculty of Engineering and Physical Sciences.

At postgraduate level, the group has a large and diverse community of PhD students. It also offers a modular MSc in Physics and Computing in Medicine and Biology

Clinical service

Members of the Centre contribute to the provision of clinical service at Salford Royal NHS Foundation Trust.

Technology transfer and industrial liaison

This brings a range of benefits to the Centre's research activity (funding, access to data, developing alliances) and since 1996 has resulted in the creation of three externally-funded spin-off companies, set up to exploit different aspects of research.

The Centre's research is strengthened by an industrial research partnership with Philips Medical Systems in the development of MR imaging, and an imaging biomarker strategic alliance with AstraZeneca, which supports long-term work on image-based methods for measuring disease progression and response to treatment.